title: Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
abstract: Twenty patients with obsessive compulsive disorder were treated openly with fluoxetine for 20 weeks. In 10 of the patients, addition of buspirone during the last 8 weeks improved clinical response. The role of augmenting strategies is discussed.
authors.affiliation: Harvard Medical School, Boston, Mass.
authors.forename: M A
authors.initials: MA
authors.lastname: Jenike
authors.forename: L
authors.initials: L
authors.lastname: Baer
authors.forename: L
authors.initials: L
authors.lastname: Buttolph
mesh_terms: D002065:Buspirone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D010865:Pilot Projects; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales
chemical_list: D005473:Fluoxetine; D002065:Buspirone